BioCentury | Sep 25, 2020
Management Tracks

Lopes-Fernandes to lead BD for Ipsen; plus

...Inc.Tanisha Carino, EVP and chief corporate affairs officer of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), has joined the Patient-Centered Outcomes Research Institute’s...
BioCentury | Sep 9, 2020
Product Development

McMurry-Heath: COVID-19 raises stakes for industry to take the lead on promoting science: a BioCentury audio interview

...them to our resource settings is an interesting question and conundrum. [00:09:59] You know, the Patient-Centered Outcomes Research Institute...
BioCentury | May 16, 2020
Politics, Policy & Law

New BIO leader McMurry-Heath to focus on patients and innovation

...been deeply involved in patient engagement initiatives, serving on the board of governors of the Patient-Centered Outcomes Research Institute (PCORI)...
BioCentury | Apr 8, 2020
Deals

COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more

...virus escape and reduce inflammation to prevent acute respiratory syndrome. PCORI funding hydroxychloroquine trial The Patient-Centered Outcomes Research Institute...
BioCentury | Jan 17, 2020
Company News

Management tracks: Sun departs as Hengrui chair; plus Blackstone, Ipsen, bluebird, BioNTech, Catalent, Foundation, Twist, Lantheus, Abcam and more

...affairs of oncology, endocrinology and rare diseases at Ipsen Biopharmaceuticals, Ipsen Group’s U.S. affiliate. The Patient-Centered Outcomes Research Institute...
BioCentury | Dec 11, 2019
Company News

Management tracks: Elevate hires CSO of regenerative medicine; plus BridgeBio, Acceleron, Flexion, Locana, Nkarta and more

...from SVP, global head of commercial and medical affairs. Joe Selby, the executive director of Patient-Centered Outcomes Research Institute...
BioCentury | Dec 6, 2019
Politics & Policy

Revised Grassley, Wyden drug pricing bill more patient- and pharma-friendly

...to expire at year end. It also would extend the trust fund that supports the Patient-Centered Outcomes Research Institute (PCORI)...
BioCentury | Oct 22, 2019
Politics & Policy

Bipartisan Policy Center calls for U.S. to adopt external, internal reference pricing

...pricing To support internal reference pricing policies, the BPC called on Congress to reauthorize the Patient-Centered Outcomes Research Institute (PCORI)...
...beneficiary cost-sharing for drugs to promote cost-based decision-making. Steve Usdin, Washington Editor Bipartisan Policy Center drug prices Medicare Part B Patient-Centered Outcomes Research Institute (PCORI) H.R...
BioCentury | Jul 13, 2018
Company News

Pilot supports real-world endpoints as surrogates for OS

Friends of Cancer Research released data on July 10 that support the use of real-world evidence (RWE) outcomes -- including real-world progression-free survival (rwPFS) -- as surrogate endpoints for overall survival to evaluate a treatment's...
BioCentury | Jul 10, 2018
Clinical News

Pilot supports real-world endpoints as surrogates for OS

Friends of Cancer Research released data Tuesday that support the use of real-world evidence (RWE) outcomes -- including real-world progression-free survival (rwPFS) -- as surrogate endpoints for overall survival to evaluate a treatment's long-term effects....
Items per page:
1 - 10 of 75
BioCentury | Sep 25, 2020
Management Tracks

Lopes-Fernandes to lead BD for Ipsen; plus

...Inc.Tanisha Carino, EVP and chief corporate affairs officer of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), has joined the Patient-Centered Outcomes Research Institute’s...
BioCentury | Sep 9, 2020
Product Development

McMurry-Heath: COVID-19 raises stakes for industry to take the lead on promoting science: a BioCentury audio interview

...them to our resource settings is an interesting question and conundrum. [00:09:59] You know, the Patient-Centered Outcomes Research Institute...
BioCentury | May 16, 2020
Politics, Policy & Law

New BIO leader McMurry-Heath to focus on patients and innovation

...been deeply involved in patient engagement initiatives, serving on the board of governors of the Patient-Centered Outcomes Research Institute (PCORI)...
BioCentury | Apr 8, 2020
Deals

COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more

...virus escape and reduce inflammation to prevent acute respiratory syndrome. PCORI funding hydroxychloroquine trial The Patient-Centered Outcomes Research Institute...
BioCentury | Jan 17, 2020
Company News

Management tracks: Sun departs as Hengrui chair; plus Blackstone, Ipsen, bluebird, BioNTech, Catalent, Foundation, Twist, Lantheus, Abcam and more

...affairs of oncology, endocrinology and rare diseases at Ipsen Biopharmaceuticals, Ipsen Group’s U.S. affiliate. The Patient-Centered Outcomes Research Institute...
BioCentury | Dec 11, 2019
Company News

Management tracks: Elevate hires CSO of regenerative medicine; plus BridgeBio, Acceleron, Flexion, Locana, Nkarta and more

...from SVP, global head of commercial and medical affairs. Joe Selby, the executive director of Patient-Centered Outcomes Research Institute...
BioCentury | Dec 6, 2019
Politics & Policy

Revised Grassley, Wyden drug pricing bill more patient- and pharma-friendly

...to expire at year end. It also would extend the trust fund that supports the Patient-Centered Outcomes Research Institute (PCORI)...
BioCentury | Oct 22, 2019
Politics & Policy

Bipartisan Policy Center calls for U.S. to adopt external, internal reference pricing

...pricing To support internal reference pricing policies, the BPC called on Congress to reauthorize the Patient-Centered Outcomes Research Institute (PCORI)...
...beneficiary cost-sharing for drugs to promote cost-based decision-making. Steve Usdin, Washington Editor Bipartisan Policy Center drug prices Medicare Part B Patient-Centered Outcomes Research Institute (PCORI) H.R...
BioCentury | Jul 13, 2018
Company News

Pilot supports real-world endpoints as surrogates for OS

Friends of Cancer Research released data on July 10 that support the use of real-world evidence (RWE) outcomes -- including real-world progression-free survival (rwPFS) -- as surrogate endpoints for overall survival to evaluate a treatment's...
BioCentury | Jul 10, 2018
Clinical News

Pilot supports real-world endpoints as surrogates for OS

Friends of Cancer Research released data Tuesday that support the use of real-world evidence (RWE) outcomes -- including real-world progression-free survival (rwPFS) -- as surrogate endpoints for overall survival to evaluate a treatment's long-term effects....
Items per page:
1 - 10 of 75